EU Approves Groundbreaking HIV Preventive Treatment: A Major Health Milestone!
With this new drug, individuals will only need to administer an injection twice a year. MEXICO CITY (apro).- On Wednesday, June 18, the U.S. Food and Drug Administration (FDA) approved a new preventive treatment for Human Immunodeficiency Virus (HIV). The biopharmaceutical company Gilead Sciences announced that their drug Lenacapavir, marketed as Yeztugo, can prevent the … Read more



